Furthermore, naringin may upregulate hepatic and adipocyte PPARγ and GLUT4 to regulate the expression of hepatic enzymes involved in glycolysis and gluconeogenesis, thereby improving hyperglycemia [128]. The gene discussed is SLC2A4; the disease is Hyperglycemia.